This press release contains statements concerning our expectations, anticipations and beliefs regarding the future, which constitute 「forward-looking statements」 within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements, which are based on assumptions that we have made as of the date hereof and are subject to known and unknown risks and uncertainties, often contain words such as 「anticipate,」 「believe,」 「estimate,」 「expect,」 「guidance,」 「intend,」 「may,」 「outlook,」 「scenario,」 「should,」 「would,」 and 「will」. Forward-looking statements may include statements regarding: our 2024 company and segment outlooks, including expected market pricing of lithium and spodumene and other underlying assumptions and outlook considerations; expected capital expenditure amounts and the corresponding impact on cash flow; market pricing of lithium carbonate equivalent and spodumene; plans and expectations regarding other projects and activities, cost reductions and accounting charges, and all other information relating to matters that are not historical facts. Factors that could cause Albemarle’s actual results to differ materially from the outlook expressed or implied in any forward-looking statement include: changes in economic and business conditions; financial and
4
operating performance of customers; timing and magnitude of customer orders; fluctuations in lithium market prices; production volume shortfalls; increased competition; changes in product demand; availability and cost of raw materials and energy; technological change and development; fluctuations in foreign currencies; changes in laws and government regulation; regulatory actions, proceedings, claims or litigation; cyber-security breaches, terrorist attacks, industrial accidents or natural disasters; political unrest; changes in inflation or interest rates; volatility in the debt and equity markets; acquisition and divestiture transactions; timing and success of projects; performance of Albemarle’s partners in joint ventures and other projects; changes in credit ratings; and the other factors detailed from time to time in the reports Albemarle files with the SEC, including those described under 「Risk Factors」 in Albemarle’s most recent Annual Report on Form 10-k and any subsequently filed Quarterly Reports on Form 10-Q, which are filed with the SEC and available on the investor section of Albemarle’s website (investors.albemarle.com) and on the SEC’s website at www.sec.gov. These forward-looking statements speak only as of the date of this press release. Albemarle assumes no obligation to provide any revisions to any forward-looking statements should circumstances change, except as otherwise required by securities and other applicable laws.
(1)公司在2024年9月30日結束的九個月內採取了若干行動,作爲更廣泛努力的一部分,將專注於保留其世界一流的資源優勢,優化全球轉換網絡,提高公司的成本競爭力和效率,降低資本強度,並增強公司的財務靈活性。這些行動包括停止Kemerton火車3和4號車廂的施工,以及某些其他資本項目,並將Kemerton火車2號車廂投入保養。因此,公司在2024年9月30日結束的三個和九個月內,分別在銷售成本中錄得1650萬美元的重組費用,並在2024年9月30日結束的三個和九個月內,分別在重組費用和資產寫下中錄得82810萬美元和12億美元。此外,與這些行動有關的三個和九個月至2024年9月30日結束的其他(費用)收入中,分別錄得1620萬美元和2150萬美元的損失。總體而言,這導致了93000萬美元的稅後損失 或分別爲截至2024年9月30日結束的三個和九個月的每股價格分別爲7.91美元和9.99美元。稅收影響包括保留估值準備金以抵消澳大利亞費用相關的稅收收益。在截至2023年9月30日結束的三個和九個月期間,公司和Ketjen業務的員工分離和其他離職費用分別在銷售總務及管理費用中錄得180萬美元和920萬美元(130萬美元 $700萬 after income taxes, or $0.01 and $0.06 per share), respectively.
(2)Costs related to the acquisition, integration and divestitures for various significant projects, recorded in Selling, general and administrative expenses for the three and nine months ended September 30, 2024 were $40萬 and $390萬 ($40萬 and $310萬 after income taxes, or less than $0.01 and $0.03 per share), respectively, and for the three and nine months ended September 30, 2023 were $1000萬 and $2170萬 ($780萬 and $1680萬 after income taxes, or $0.07 and $0.14 per share), respectively.
11
(3)Losses of $500萬 and $3220萬 recorded in Other (expenses) income, net resulting from the net change in fair value of investments in public equity securities for the three and nine months ended September 30, 2024, respectively, and a loss of $3370萬 recorded in Other (expenses) income, net for the nine months ended September 30, 2024 resulting from the sale of investments in public equity securities ($390萬 and $5890萬 after income taxes, or $0.03 and $0.50 per share). Loss (gain) of $2640萬 and ($34.4) million ($2050萬 and ($25.2) million after income taxes, or $0.17 and ($0.21) per share) recorded in Other (expenses) income, net for the three and nine months ended September 30, 2023, respectively, resulting from the net change in fair value of investments in public equity securities.
(4)Accrual of $21850萬 ($21490萬 after income taxes, or $1.82 per share) recorded in Selling, general and administrative expenses resulting from agreements in principle to resolve a previously disclosed legal matter with the DOJ and SEC related to conduct in our Ketjen business prior to 2018.